Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-018138
Filing Date
2024-04-25
Accepted
2024-04-25 16:01:22
Documents
19
Period of Report
2024-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A cdxc-20240425.htm   iXBRL DEF 14A 667913
5 cdxc-20240425_g1.jpg GRAPHIC 5296
6 cdxc-20240425_g2.jpg GRAPHIC 102894
7 cdxc-20240425_g3.jpg GRAPHIC 89376
8 cdxc-20240425_g4.jpg GRAPHIC 89991
9 cdxc-20240425_g5.jpg GRAPHIC 185020
10 cdxc-20240425_g6.jpg GRAPHIC 146351
  Complete submission text file 0001628280-24-018138.txt   2804997

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20240425.xsd EX-101.SCH 4866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20240425_lab.xml EX-101.LAB 10454
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20240425_pre.xml EX-101.PRE 6455
22 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20240425_htm.xml XML 100737
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37752 | Film No.: 24876042
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)